Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisong Teng

Showing results (41-50 of 190) with videos related to

Pageof 19
Sort By:
Oncology Letters|October 23, 2018
Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 ×enograftsJun Zhang, Yangjun Zhu, Mengjie Dong, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Hepatitis B Virus Infection Is Associated with a Higher Risk of Liver Metastasis in Gastric CancerSongting Zhu, Mengmeng Jiang, Yanyan Chen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 17, 2010
Aflibercept (VEGF Trap): one more double-edged sword of anti-VEGF therapy for cancer?Ketao Jin, Yanping Shen, Kuifeng He, et al.
Oncotargets and Therapy|May 10, 2012
The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)Kuifeng He, Binbin Cui, Guangliang Li, et al.
Oncotargets and Therapy|December 14, 2011
Surgical management of retrorectal tumors: a retrospective study of a 9-year experience in a single institutionCaizhao Lin, Ketao Jin, Huanrong Lan, et al.
Hepato-Gastroenterology|April 27, 2012
FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effectsWeili Gao, Ketao Jin, Huanrong Lan, et al.
Oncotargets and Therapy|September 12, 2014
ER-α36: a novel biomarker and potential therapeutic target in breast cancerXingyun Su, Xin Xu, Guangliang Li, et al.
Journal of Oncology|October 20, 2022
The lncRNA NEAT1 Inhibits miRNA-216b and Promotes Colorectal Cancer Progression by Indirectly Activating YY1Yuping Zhu, Xuanying Wang, Linfeng Zheng, et al.
Oncology Letters|August 7, 2012
Synchronous primary carcinomas of the rectum and prostate: Report of three casesCaizhao Lin, Ketao Jin, Hanju Hua, et al.
International Journal of Biological Sciences|November 10, 2025
<i>Lactobacillus paracasei</i> ZJUZ2-3 inhibits gastrointestinal tumors via the IAA-induced AHR/MTDH/NF-κB axisRui Yang, Yan Yang, Lin Wu, et al.
Pageof 19

Showing results (41-50 of 190) with videos related to

Sort By:
Pageof 19
Oncology Letters|October 23, 2018
Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 ×enograftsJun Zhang, Yangjun Zhu, Mengjie Dong, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Hepatitis B Virus Infection Is Associated with a Higher Risk of Liver Metastasis in Gastric CancerSongting Zhu, Mengmeng Jiang, Yanyan Chen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 17, 2010
Aflibercept (VEGF Trap): one more double-edged sword of anti-VEGF therapy for cancer?Ketao Jin, Yanping Shen, Kuifeng He, et al.
Oncotargets and Therapy|May 10, 2012
The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)Kuifeng He, Binbin Cui, Guangliang Li, et al.
Oncotargets and Therapy|December 14, 2011
Surgical management of retrorectal tumors: a retrospective study of a 9-year experience in a single institutionCaizhao Lin, Ketao Jin, Huanrong Lan, et al.
Hepato-Gastroenterology|April 27, 2012
FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effectsWeili Gao, Ketao Jin, Huanrong Lan, et al.
Oncotargets and Therapy|September 12, 2014
ER-α36: a novel biomarker and potential therapeutic target in breast cancerXingyun Su, Xin Xu, Guangliang Li, et al.
Journal of Oncology|October 20, 2022
The lncRNA NEAT1 Inhibits miRNA-216b and Promotes Colorectal Cancer Progression by Indirectly Activating YY1Yuping Zhu, Xuanying Wang, Linfeng Zheng, et al.
Oncology Letters|August 7, 2012
Synchronous primary carcinomas of the rectum and prostate: Report of three casesCaizhao Lin, Ketao Jin, Hanju Hua, et al.
International Journal of Biological Sciences|November 10, 2025
<i>Lactobacillus paracasei</i> ZJUZ2-3 inhibits gastrointestinal tumors via the IAA-induced AHR/MTDH/NF-κB axisRui Yang, Yan Yang, Lin Wu, et al.
Pageof 19